REATA PHARMACEUTICALS INC 4 SEC Filings

Filed On	Filing
28 Sep 2023	Form 4: Desai Antal Rohit, Director and 1 other Returned 2,928,368 shares to the issuer · Disposed of 1,692,857 Class B common stock (Disposition to Issuer)
26 Sep 2023	Form 4: McGaughy R Kent Jr, Director Returned 2,926,776 shares to the issuer · Disposed of 2,025,370 Class B common stock (Disposition to Issuer) · Disposed of 66,712 Stock Option (right to buy) (Disposition to Issuer) · 1 more
26 Sep 2023	Form 4: Wortley Michael D, Chief Legal Officer Returned 49,701 shares to the issuer · Disposed of 366,350 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Oliger Christy J., Director Returned 5,565 shares to the issuer · Disposed of 24,293 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Loewen Andrea, SVP, Global Regulatory Affairs Returned 28,416 shares to the issuer · Disposed of 102,988 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Soni Manmeet Singh, COO, CFO and President Returned 62,621 shares to the issuer · Disposed of 519,475 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Rose William, Director Returned 599,583 shares to the issuer · Disposed of 2,038,102 Class B Common Stock (Disposition to Issuer) · Disposed of 69,422 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Ruff Shamim, Director Returned 7,359 shares to the issuer · Disposed of 13,675 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Meyer Colin John, Chief Innovation Officer Returned 81,633 shares to the issuer · Disposed of 74,304 Class B common stock (Disposition to Issuer) · Disposed of 493,175 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Bir Dawn Carter, Chief Commercial Officer Returned 33,805 shares to the issuer · Disposed of 314,450 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Patni Rajiv, EVP, Chief R&D Officer Returned 45,000 shares to the issuer · Disposed of 90,000 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Ryder Steven, Director Returned 10,907 shares to the issuer · Disposed of 15,430 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Huff James Warren, Director Returned 132,878 shares to the issuer · Disposed of 212,903 Class B common stock (Disposition to Issuer) · Disposed of 857,229 Employee Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Edwards Martin, Director Returned 6,116 shares to the issuer · Disposed of 29,845 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: McClellan William D. Jr., Director Returned 6,017 shares to the issuer · Disposed of 43,207 Stock Option (right to buy) (Disposition to Issuer)
26 Sep 2023	Form 4: Anand Bhaskar, SVP, Chief Accounting Officer Returned 24,089 shares to the issuer · Disposed of 77,938 Employee Stock Option (right to buy) (Disposition to Issuer)
19 Sep 2023	Form 4: Rose William, Director Gave 145,000 Class B Common Stock as a gift · Acquired 87,000 Class B Common Stock (Gift)
18 Sep 2023	Form 4: Loewen Andrea, SVP, Global Regulatory Affairs Sold 3,175 shares ($546K)
07 Sep 2023	Form 4: Anand Bhaskar, SVP, Chief Accounting Officer Sold 406 shares ($68.7K)
24 Aug 2023	Form 4: Rose William, Director Gave 500,000 shares as a gift

Comments